OA
Oxbow Advisors Portfolio holdings
AUM
$915M
This Quarter Return
-3.77%
1 Year Return
+17.22%
3 Year Return
+51.42%
5 Year Return
+81.66%
10 Year Return
+98.71%
AUM
$637M
AUM Growth
+$637M
(-9.6%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
36.95%
Holding
261
New
8
Increased
83
Reduced
51
Closed
19
Top Buys
Top Sells
| 1 |
iShares Gold Trust
IAU
|
$8.2M |
| 2 |
Nutrien
NTR
|
$7.86M |
| 3 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
$5.09M |
| 4 |
Chevron
CVX
|
$4.15M |
| 5 |
Franco-Nevada
FNV
|
$3.8M |
Sector Composition
| 1 | Technology | 12.91% |
| 2 | Energy | 11.99% |
| 3 | Real Estate | 6.19% |
| 4 | Financials | 5.9% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEI
251
Templeton Emerging Markets Income Fund
TEI
$290M
| – | – |
-177,283
| Closed | -$956K |
|
252
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-181,587
| Closed | -$1.37M |
|
253
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.2B
| – | – |
-4,262
| Closed | -$341K |
|
254
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38B
| – | – |
-6,533
| Closed | -$326K |
|